ArticleBiophysical journal2026
Effects of a cancer-associated mutation and multiple serine phosphorylation on poly(ADP-ribose) polymerase 2.
Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Doxorubicin-loaded chitosan-silver nanocarrier elicits chemoresistance in liver cancer cells.Medical oncology (Northwood, London, England) · 2026Article
- Rational design of immunological programs for functional regenerative niches.Materials today. Bio · 2026Review
- Advances in oncolytic virus delivery strategies and challenges in clinical translation.Materials today. Bio · 2026Review
- Biomimetic villi-crypt scaffold-on-chip with tunable mechanical properties for intestinal epithelium modeling.Materials today. Bio · 2026Article
- Mesoporous silica nanoparticles functionalized with folic acid and zinc for enhanced targeted delivery of daunorubicin to breast cancer cells.Scientific reports · 2026Article
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities.BMC biotechnology · 2026Article
- Magnetic nanoparticles as promising materials for the future of medicine.Journal of materials science. Materials in medicine · 2026Review
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Poly(ADP-ribose) polymerase 2 (PARP2) plays a crucial role in DNA repair. A common single-nucleotide polymorphism (SNP) in the PARP2 gene, rs3093921, has been associated with pancreatic cancer and marginal zone lymphoma. This SNP results in a missense mutation, D235G, in the PARP2 protein. PARP2 is also reported to undergo posttranslational modifications (PTMs), particularly phosphorylation at serine residues 226, 232, and 353. The C-terminal region of PARP2 includes the Trp-Gly-Arg (WGR) domain, the ADP-ribosyl transferase (ART) domain, and the helical subdomain (HD). The latter two, spanning residues 220-583, comprise the catalytic region of PARP2. The DNA-induced enzymatic activation of PARP2 is regulated by local destabilization of the HD domain. We used molecular dynamics simulations to investigate the impact of these three PTMs on both the wild-type (WT) and the mutant (D235G) forms of PARP2. Our simulations suggest that the mutation leads to a change in structure and residual flexibility in specific regions of the HD domain compared with the WT. The presence of the PTMs also shows altered structure of the HD domain, although the residual flexibility remains unchanged compared with the unmodified WT. This is further supported by the destabilizing interactions between the mutation site and the HD domain observed in the presence of both the mutation and the PTMs. Importantly, our results suggest that the three PTMs mitigate the changes in structure and residual flexibility caused by the mutation, helping the PTM-modified mutant protein retain WT-like features. We observe that, while the PTMs alter the dominant mode of motion in the native protein, this shift is not observed in the mutant, further indicating that PTMs mitigate the structural and dynamic consequences of the mutation, preserving WT-like behavior. The mutation and PTMs cause notable changes in correlated motions within the WGR and ART domains, with the PTM-modified mutant structure showing the strongest correlations. Interestingly, a similar trend is observed for anticorrelated motions, particularly between the WGR and ART domains, where the PTM-modified mutant structure again exhibits the highest level of anticorrelation. Additionally the mutation in PARP2 markedly weakens interdomain interactions between the HD and ART domains, as well as between the HD and WGR domains. By contrast, the PTMs alone show no change on the HD-ART interaction, although they weaken the HD-WGR interaction. For the PTM-modified mutant structure the HD-ART interaction remains disrupted compared with the WT, but the extent of disruption is less than that caused by the mutation alone-suggesting a partial compensatory effect of the PTMs. Additionally, the HD-WGR interaction remains consistently weakened in all modified systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.